Virtually Supervised Exercise for Kidney Transplant Candidates

NCT ID: NCT05355545

Last Updated: 2025-07-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-18

Study Completion Date

2026-07-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is examining whether a virtually supervised exercise program can improve physical function in persons who are awaiting kidney transplant. The investigators will compare the results to a similar group of persons who receive a health education program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is examining if a virtually supervised exercise program can improve physical function in persons awaiting kidney transplant. A double-blind, parallel group randomized controlled clinical trial, this study will enroll 80 persons for 24 weeks. Our primary outcome is performance on the 30 second sit to stand test, and our secondary outcomes are changes in the Fatigue Severity Scale and the Beck Depression Inventory.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physical Disability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study uses a parallel group delayed intervention design. In the first half of the study (Weeks 0 to 12), the intervention arm will receive the virtually supervised exercise intervention, while the active comparator arm will receive the health education program. In the second half of the study (Weeks 13 to 24), the intervention arm will continue the virtually supervised exercise intervention, while the active comparator group will start the virtually supervised exercise intervention. The primary timepoint of interest will be at 12 weeks.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtually supervised exercise

In the first half of the study (weeks 0 to 12), participants will receive a virtually supervised exercise program. In the second half of the study (weeks 13 to 24), participant will continue to receive the virtually supervised exercise program.

Group Type EXPERIMENTAL

Virtually supervised exercise

Intervention Type BEHAVIORAL

Participants will participate twice weekly in an live exercise program that they will access through a computer connected to the Internet.

Health education

In the first half of the study (weeks 0 to 12), participants will receive a health education program. In the second half of the study (weeks 13 to 24), participant will receive a the virtually supervised exercise program.

Group Type ACTIVE_COMPARATOR

Virtually supervised exercise

Intervention Type BEHAVIORAL

Participants will participate twice weekly in an live exercise program that they will access through a computer connected to the Internet.

Health education

Intervention Type BEHAVIORAL

Participants will first participate in a once weekly live health education class that they will access through a computer connected to the Internet. During the second half of the study, participants will participate twice weekly in an live exercise program that they will access through a computer connected to the Internet.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtually supervised exercise

Participants will participate twice weekly in an live exercise program that they will access through a computer connected to the Internet.

Intervention Type BEHAVIORAL

Health education

Participants will first participate in a once weekly live health education class that they will access through a computer connected to the Internet. During the second half of the study, participants will participate twice weekly in an live exercise program that they will access through a computer connected to the Internet.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 18 years old
* Listed for kidney transplant
* Positive answers (e.g. yes) to one of the following:

* current difficulty with climbing up 10 stairs,
* has changed in the past year how they climb 10 stairs
* current difficulty with walking a 0.5 mile (5-6 blocks)
* has changed in past year in how they walk 0.5 mile (5-6 blocks)
* documented performance of 430 meters or less on the six minute walk test in the past 12 months
* documented performance of 9 points or less on the Short Physical Performance Battery in the past 24 months
* documented performance of less than 3 points or less on the five times sit to stand test in the past 24 months
* Demonstrated ability to stand up independently from a seated position and then sit back down without using their arms or an assistive device in the past 24 months

Exclusion Criteria

* Does not speak English or Spanish
* Nursing home resident
* Severe low vision (≥20/200 with corrective lens)
* Severe hearing loss even with use of amplification preventing communication
* Unstable angina or uncontrolled arrhythmia
* Supplemental oxygen therapy
* Myocardial infarction, major heart surgery, stroke, venous thromboembolism, hip fracture, hip or knee replacement in past six months (temporary exclusion)
* ≥ 3 errors on the Six Item Screener
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

Sponsor Role collaborator

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christine Liu

Assistant Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stanford University

Palo Alto, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christine K Liu, MD

Role: CONTACT

650-723-1365

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christine Liu, MD

Role: primary

650 723 1365

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01DK133509-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

65020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CAPABLE Transplant
NCT06326905 RECRUITING NA